Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis

Show other versions (1)

Bibliographic Details
Main Authors:	Isaacs, J, Clarke, A, Hazleman, B, Hale, G, Waldmann, H, Symmons, D
Format:	Conference item
Published:	2005

Similar Items

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
by: Isaacs, J, et al.
Published: (2005)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
by: Isaacs, J, et al.
Published: (2004)

Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA.
by: Isaacs, J, et al.
Published: (1998)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
by: Isaacs, J, et al.
Published: (1992)

Humanised monoclonal antibody therapy for rheumatoid arthritis.
by: Isaacs, J, et al.
Published: (1992)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
by: Kyle, V, et al.
Published: (1991)

Morbidity not increased in rheumatoid arthritis patient with profound lymphopenia following CD4 monoclonal antibody therapy: comment on the article by Isaacs et al - Reply
by: Isaacs, J, et al.
Published: (2002)

Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
by: Lockwood, C, et al.
Published: (1993)

MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
by: Isaacs, J, et al.
Published: (1993)

Morbidity and mortality in rheumatoid arthritis patients with prolonged therapy-induced lymphopenia: twelve-year outcomes.
by: Lorenzi, A, et al.
Published: (2008)

Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.
by: Isaacs, J, et al.
Published: (2001)

TREATMENT OF RHEUMATOID-ARTHRITIS WITH HUMANIZED ANTILYMPHOCYTE ANTIBODY CAMPATH-1H
by: Watts, R, et al.
Published: (1992)

Aglycosyl anti-CD3 monoclonal antibody therapy in rheumatoid arthritis - Results of a pilot safety study
by: Lawson, C, et al.
Published: (2005)

Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis.
by: Kyle, V, et al.
Published: (1989)

Combination therapy with a TNF antagonist and a CD4 monoclonal antibody in rheumatoid arthritis. A pilot study.
by: Morgan, A, et al.
Published: (1997)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
by: Isaacs, J, et al.
Published: (1996)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
by: Lockwood, C, et al.
Published: (1993)

Antibody therapy for rheumatoid arthritis.
by: Taylor, P
Published: (2003)

HUMANIZED MONOCLONAL-ANTIBODY (MAB) THERAPY FOR WEGENERS GRANULOMATOSIS (WG)
by: Lockwood, C, et al.
Published: (1995)

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans.
by: Isaacs, J, et al.
Published: (1996)

Monoclonal-antibody therapy in systemic vasculitis.
by: Mathieson, P, et al.
Published: (1990)

Therapy with monoclonal antibodies. An in vivo model for the assessment of therapeutic potential.
by: Isaacs, J, et al.
Published: (1992)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
by: Dyer, M, et al.
Published: (1988)

Induction of tolerance by monoclonal antibody therapy.
by: Benjamin, R, et al.
Published: (1986)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
by: Isaacs, J, et al.
Published: (1995)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
by: Elliot, M, et al.
Published: (2008)

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.
by: Elliott, M, et al.
Published: (1993)

NI-0101, a Therapeutic TLR4 Monoclonal Antibody for Rheumatoid Arthritis
by: Elson, G, et al.
Published: (2011)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
by: Elliott, M, et al.
Published: (1994)

MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
by: Mathieson, P, et al.
Published: (1990)

CAMPATH-1H in inflammatory arthritis.
by: Watts, R, et al.
Published: (1993)

MONOCLONAL-ANTIBODIES TO HEMATOPOIETIC-CELLS
by: Waldmann, H, et al.
Published: (1982)

The long-term complications of non-fatal rheumatoid arthritis
by: Taylor, P
Published: (2018)

A pilot study of combination anti-cytokine and anti-lymphocyte biological therapy in rheumatoid arthritis.
by: Morgan, A, et al.
Published: (2008)

Advantages of rat monoclonal antibodies.
by: Clark, M, et al.
Published: (1983)

Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.
by: Isaacs, J, et al.
Published: (1997)

BIOLOGICAL EFFECTS OF A HUMAN IGG4 MONOCLONAL-ANTIBODY IN-VIVO
by: Isaacs, J, et al.
Published: (1995)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
by: Lim, S, et al.
Published: (1993)

Specificity of monoclonal antibody Campath-1.
by: Hale, G, et al.
Published: (1988)

Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies.
by: Lockwood, C, et al.
Published: (1996)